Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

Abstract

In patients on newly prescribed donepezil, the primary reason for discontinuation was an adverse event. Cognitive assessments revealed no significant worsening at 1 year, indicating that continuous donepezil treatment contributes to the maintenance of cognitive function.